# Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

Study · id `cardio:ct-nct06552637` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06552637](<https://clinicaltrials.gov/study/NCT06552637>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06552637

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.

## Technical summary

Registry record NCT06552637. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-08 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 270 participants (planned count; ClinicalTrials.gov record NCT06552637, source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)
- Started: 2026-07-08 (actual) (ClinicalTrials.gov record NCT06552637, source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT06552637, source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT06552637, source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)
- Countries: United States; Georgia (ClinicalTrials.gov record NCT06552637, source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06552637-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Acronym: RECOVER-HF
- Condition: Heart Failure With Reduced Ejection Fraction
- Intervention (Device): Synchronized Diaphragmatic Stimulation
- Lead sponsor: VisCardia Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Clinical Accelerator
- Collaborator class: INDUSTRY
- Collaborator: Duke Clinical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Duke Clinical Research Institute (`cardio:org-duke-clinical-research-institute`)

## Provenance

Content hash: 966207b380196d5abd9e8ee8dad9625ec7b97f429a7c4138b7e6d348a75bd42d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
